CD4 and lung adenocarcinoma: Our study presents novel insights into the critical role of TAGAP in Lung Adenocarcinoma (LUAD), emphasizing its prognostic potential, relationship with immune cell infiltration, influence on CD4+ T cell activity, and predictive value for immunotherapy responsiveness.